» Articles » PMID: 33319423

Mrr1 Regulation of Methylglyoxal Catabolism and Methylglyoxal-induced Fluconazole Resistance in Candida Lusitaniae

Overview
Journal Mol Microbiol
Date 2020 Dec 15
PMID 33319423
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription factor Mrr1, best known for its regulation of Candida azole resistance genes such as MDR1, regulates other genes that are poorly characterized. Among the other Mrr1-regulated genes are putative methylglyoxal reductases. Methylglyoxal (MG) is a toxic metabolite that is elevated in diabetes, uremia, and sepsis, which are diseases that increase the risk for candidiasis, and MG serves as a regulatory signal in diverse organisms. Our studies in Clavispora lusitaniae, also known as Candida lusitaniae, showed that Mrr1 regulates expression of two paralogous MG reductases, MGD1 and MGD2, and that both participate in MG resistance and MG catabolism. Exogenous MG increased Mrr1-dependent expression of MGD1 and MGD2 as well as expression of MDR1, which encodes an efflux pump that exports fluconazole. MG improved growth in the presence of fluconazole and this was largely Mrr1-dependent with contributions from a secondary transcription factor, Cap1. Increased fluconazole resistance was also observed in mutants lacking Glo1, a Mrr1-independent MG catabolic enzyme. Isolates from other Candida species displayed heterogeneity in MG resistance and MG stimulation of azole resistance. We propose endogenous and host-derived MG can induce MDR1 and other Mrr1-regulated genes causing increased drug resistance, which may contribute to some instances of fungal treatment failure.

Citing Articles

Adaptation of Candida albicans to specific host environments by gain-of-function mutations in transcription factors.

Morschhauser J PLoS Pathog. 2024; 20(11):e1012643.

PMID: 39495716 PMC: 11534201. DOI: 10.1371/journal.ppat.1012643.


LasR-deficient mutants have increased methylglyoxal and hydrogen peroxide sensitivity due to low intracellular glutathione.

Ruzic M, Hefferan A, Conaway A, Hogan D bioRxiv. 2024; .

PMID: 39386711 PMC: 11463435. DOI: 10.1101/2024.09.25.615034.


Drivers of diversification in fungal pathogen populations.

Murante D, Hogan D PLoS Pathog. 2024; 20(9):e1012430.

PMID: 39264909 PMC: 11392411. DOI: 10.1371/journal.ppat.1012430.


Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance.

Doorley L, Rybak J, Berkow E, Zhang Q, Morschhauser J, Rogers P Antimicrob Agents Chemother. 2022; 66(7):e0028922.

PMID: 35699442 PMC: 9295576. DOI: 10.1128/aac.00289-22.


Oxidative stress response pathways in fungi.

Yaakoub H, Mina S, Calenda A, Bouchara J, Papon N Cell Mol Life Sci. 2022; 79(6):333.

PMID: 35648225 PMC: 11071803. DOI: 10.1007/s00018-022-04353-8.


References
1.
Lapolla A, Flamini R, Lupo A, Arico N, Rugiu C, Reitano R . Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis. Ann N Y Acad Sci. 2005; 1043:217-24. DOI: 10.1196/annals.1333.027. View

2.
Zuin A, Vivancos A, Sanso M, Takatsume Y, Ayte J, Inoue Y . The glycolytic metabolite methylglyoxal activates Pap1 and Sty1 stress responses in Schizosaccharomyces pombe. J Biol Chem. 2005; 280(44):36708-13. DOI: 10.1074/jbc.M508400200. View

3.
Letunic I, Bork P . Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2006; 23(1):127-8. DOI: 10.1093/bioinformatics/btl529. View

4.
Maeta K, Izawa S, Okazaki S, Kuge S, Inoue Y . Activity of the Yap1 transcription factor in Saccharomyces cerevisiae is modulated by methylglyoxal, a metabolite derived from glycolysis. Mol Cell Biol. 2004; 24(19):8753-64. PMC: 516737. DOI: 10.1128/MCB.24.19.8753-8764.2004. View

5.
Znaidi S, Weber S, Zin Al-Abdin O, Bomme P, Saidane S, Drouin S . Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell. 2008; 7(5):836-47. PMC: 2394978. DOI: 10.1128/EC.00070-08. View